A comparative study of dalteparin and unfractionated heparin in patients with unstable angina pectoris

Indian Journal of Pharmacology

Volumn 43, Issue 6, 2011, Pages 703-706

  Amane, Hanmant S ^a   Burte, N P ^b  

^a SDM COLLEGE OF MEDICAL SCIENCES AND HOSPITAL   (India)

^b MNR Medical College   (India)

Author keywords

Anticoagulant; bleeding; low molecular weight heparin; unstable angina

Indexed keywords

DALTEPARIN; HEPARIN;

ADULT; AGED; COMPARATIVE STUDY; CONFERENCE PAPER; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ELECTROCARDIOGRAPHY; EPISTAXIS; FEMALE; FOLLOW UP; HEMATURIA; HUMAN; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PARALLEL DESIGN; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

EID: 81855206664     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.89830     Document Type: Conference Paper

References (15)

1. Selwyn AP, Braunwald E. Ischemic heart disease. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, editors. Harrison's Principles of Internal Medicine Vol. 1, 14 th ed. New York: McGraw-Hill; 1994. p. 1077-85.
2. Throux P, Fuster V. Acute Coronary Syndromes. Unstable angina and Non-Q-Wave myocardial infarction. Circulation 1998;97;1195-206. (Pubitemid 28152893)
3. Theroux P, Quimet H, McCans J, Latour J, Joly P, Levy G, et al. Aspirin, heparin or both to treat acute unstable angina. N Engl J Med 1988;319;1105-11.
4. Braunwald E, Jones RH, Mark DB, Brown J, Brown L, Cheitlin MD, et al. Diagnosing and Managing unstable angina. Circulation 1994;90:613-22. (Pubitemid 24203726)
5. Weitz JI. Low-molecular-weight heparins. N Engl J Med 1997;337:688-98. (Pubitemid 27375477)
6. Nurmohamed MT, Rosendaol FR, Buller HR. Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: A meta-analysis. Lancet 1992;340:152-6.
7. Leizorovicz A, Haugh MC, Chapuis FR, Samama MM, Boissel JB. Low-molecular-weight heparin in prevention of perioperative thrombosis. BMJ 1992;305:913-20.
8. Spiro JE, Johnson GJ, Christie MJ, Lyons RM, MacFarlane DE, Blasier RB, et al. Efficacy and safety of enoxaparin to prevent deep venous thrombosis after hip replacement surgery. Enoxaparin Clinical Trial Group. Ann Intern Med 1994;121:81-9. (Pubitemid 24203489)
9. Klein W, Buchwald A, Hillis SE, Monrad S, Sanz G, Turpie GG, et al. Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease study (FRIC). Circulation 1997;96:61-8. (Pubitemid 27298405)
10. Fragmin during Instability in coronary artery disease (FRISC) study group. Low-molecular-weight heparin during instability in coronary artery disease. Lancet 1996;347:561-8.
11. Gurfinkel EP, Manos EJ, Mejail RI, Cerdá MA, Duronto EA, García CN, et al. Low-molecular-weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia. J Am Coll Cardiol 1995;26:313-8.
12. Kay R, Wong KS, Yu YL, Chan YW, Tsoi TH, Ahuja AT, et al. Low-molecular-weight heparin for the treatment of acute ischemic stroke. N Engl J Med 1995;333:1588-93.
13. Cohen M, Christine D, Enrique P, Gurfinkel MD, Alexander GG, Turpie Gregg JF, et al. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. N Engl J Med 1997;337:447-52. (Pubitemid 27333045)
14. Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin N Engl J Med 1995;332:1330-5.
15. Eikebloom JW, Anand SS, Malmberg K, Weitz JI, Ginsberg JS, Yusuf S. Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST-elevation: A meta analysis. Lancet 2000;355:1936-42. (Pubitemid 30326097)